GO:0071676 negative regulation of mononuclear cell migration: Immune Cell Trafficking Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071676 describes any biological process that decreases the rate, frequency or extent of mononuclear cell migration, a process essential for immune surveillance and tissue homeostasis.
• Mononuclear cell migration is regulated by chemokine gradients, adhesion molecules, and inflammatory mediators such as HMGB1 and IL-27.
• Negative regulation of mononuclear cell migration is critical for resolving inflammation and preventing excessive tissue damage in diseases such as multiple sclerosis and sepsis.
• Key molecular players include MAP4K family kinases, DICAM, CXCR2, and vault particles, which modulate mononuclear phagocyte recruitment.
• Dysregulation of this process contributes to autoimmune neuroinflammation, impaired pathogen clearance, and cancer progression.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of genes controlling mononuclear cell migration.
Description
Mononuclear cell migration is a fundamental process by which monocytes, macrophages, dendritic cells, and lymphocytes move within and between tissues to carry out immune surveillance and host defense. The Gene Ontology term GO:0071676, negative regulation of mononuclear cell migration, encompasses any process that decreases the rate, frequency, or extent of this movement. This regulatory mechanism is essential for balancing effective immunity against collateral tissue damage, and its dysregulation is implicated in chronic inflammatory diseases, autoimmunity, and cancer. Understanding the molecular control of mononuclear cell migration has therefore become a major focus in immunology and translational research. Recent studies have identified diverse molecular brakes on mononuclear cell migration, including chemokine receptor desensitization, anti-inflammatory cytokines such as IL-27, and intracellular kinases like MAP4K family members. For example, inhibition of IL-27 signaling sustains CXCR2 expression on mononuclear cells and improves outcomes in gram-negative neonatal sepsis, illustrating how manipulating this regulatory axis can have therapeutic benefit. Similarly, DICAM-positive mononuclear phagocytes play a role in controlling neuroinflammation in multiple sclerosis, highlighting the clinical relevance of negative regulation. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0071676. We cover the definition, biological mechanisms, key genes, disease associations, and state-of-the-art CRISPR methods for studying this process, with the goal of supporting publication-ready research and therapeutic development.
negative regulation of mononuclear cell migration At A Glance
| GO ID | GO:0071676 |
|---|---|
| GO term | negative regulation of mononuclear cell migration |
| Ontology | biological_process |
| Synonym | down regulation of mononuclear cell migration; down-regulation of mononuclear cell migration; downregulation of mononuclear cell migration; inhibition of mononuclear cell migration |
| Major function | Decreases the rate, frequency or extent of mononuclear cell migration, thereby limiting immune cell infiltration into tissues |
| Related process | Regulation of mononuclear cell migration (GO:0071675) |
| Cellular context | Mononuclear cells including monocytes, macrophages, dendritic cells, and lymphocytes |
| Physiological role | Resolution of inflammation, prevention of autoimmune tissue damage, and maintenance of immune homeostasis |
| Pathological relevance | Dysregulation linked to chronic inflammatory diseases, autoimmunity, sepsis, and cancer |
What Is GO:0071676?
GO:0071676, negative regulation of mononuclear cell migration, is defined by QuickGO as any process that decreases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration itself refers to the movement of a mononuclear cell (such as a monocyte, macrophage, dendritic cell, or lymphocyte) within or between different tissues and organs of the body. This term is a biological process and includes synonyms such as down regulation of mononuclear cell migration, down-regulation of mononuclear cell migration, downregulation of mononuclear cell migration, and inhibition of mononuclear cell migration.
Why Is negative regulation of mononuclear cell migration Important in Cell Biology?
Negative regulation of mononuclear cell migration is a critical checkpoint that prevents excessive immune cell infiltration and tissue damage while allowing timely resolution of inflammation. Its dysregulation contributes to a broad spectrum of human diseases, including multiple sclerosis, sepsis, and cancer, making it a high-value target for therapeutic intervention. Understanding the molecular mechanisms that restrain mononuclear cell migration can inform the development of anti-inflammatory drugs, improve outcomes in infectious diseases, and enhance cancer immunotherapy.
• Prevents excessive mononuclear cell infiltration that can cause tissue damage in autoimmune diseases such as multiple sclerosis.
• Controls the resolution phase of inflammation, allowing return to homeostasis.
• Modulates host response to infection, as shown by IL-27 signaling in neonatal sepsis.
• Influences tumor microenvironment by regulating macrophage and monocyte recruitment.
• Impacts dendritic cell development and function, affecting antigen presentation.
• Involves drug resistance-related vault particles, linking to chemoresistance.
• Regulated by MAP4K family kinases, which are potential drug targets.
• Dysregulated in Kawasaki disease, a vasculitis with endothelial progenitor cell involvement.
• Key to understanding monocyte migration regulation by HMGB1.
• Provides a basis for CRISPR-based functional genomics in immunology.
What Happens During negative regulation of mononuclear cell migration?
Initiation of negative regulation by anti-inflammatory signals
In simple terms: The body sends 'stop' signals to immune cells to prevent them from moving into tissues.
Negative regulation of mononuclear cell migration begins when anti-inflammatory cytokines and mediators are released in the tissue microenvironment. For example, IL-27 signaling has been shown to regulate chemokine levels and sustain CXCR2 receptor expression on mononuclear cells, thereby modulating their migratory capacity. Similarly, negative regulation of human mononuclear phagocyte function can be initiated by anti-inflammatory stimuli that dampen migratory responses. These signals act as brakes on the chemotactic machinery that would otherwise drive cells toward inflammatory foci.
Modulation of chemokine and adhesion receptor expression
In simple terms: The cell changes the receptors on its surface so it can no longer follow the chemical trail.
A key step in negative regulation is the downregulation or desensitization of chemokine receptors and adhesion molecules on mononuclear cells. For instance, inhibition of IL-27 signaling sustains CXCR2 expression, which can enhance migration, implying that intact IL-27 signaling negatively regulates migration by reducing CXCR2. Additionally, HMGB1 (amphoterin) has been shown to regulate monocyte migration, and its modulation can affect the migratory response. The balance between pro-migratory and anti-migratory receptor signals determines the net rate of mononuclear cell migration.
Intracellular signaling pathways that inhibit migration
In simple terms: Inside the cell, specific enzymes act as brakes on the movement machinery.
Intracellular kinases such as MAP4K family kinases play critical roles in immunity and inflammation and can negatively regulate mononuclear cell migration by interfering with cytoskeletal rearrangements and integrin activation. These kinases modulate downstream pathways that control cell polarity and motility. The involvement of MAP4K family kinases highlights the complexity of the signaling networks that restrain mononuclear cell movement.
Role of specialized surface molecules and particles
In simple terms: Certain molecules on the cell surface or inside the cell help put the brakes on migration.
DICAM (dual immunoglobulin domain-containing adhesion molecule) is expressed on mononuclear phagocytes and has been implicated in controlling neuroinflammation in multiple sclerosis, suggesting a role in negative regulation of migration. Additionally, vault particles, which are drug resistance-related ribonucleoprotein complexes, are upregulated during dendritic cell development and may influence migratory behavior. These specialized components add layers of regulation to mononuclear cell trafficking.
Resolution of inflammation and return to homeostasis
In simple terms: Once the threat is gone, the stop signals keep immune cells out so tissues can heal.
The ultimate outcome of negative regulation of mononuclear cell migration is the resolution of inflammation and restoration of tissue homeostasis. By limiting the influx of mononuclear cells, this process prevents chronic inflammation and autoimmunity. In conditions such as multiple sclerosis, impaired negative regulation can lead to persistent neuroinflammation. Therefore, understanding these resolution mechanisms is essential for developing therapies that promote healing without compromising immunity.
Key Genes Involved in GO:0071676 negative regulation of mononuclear cell migration
The following genes and proteins have been experimentally implicated in the negative regulation of mononuclear cell migration, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL27 | Anti-inflammatory cytokine that regulates chemokine levels and CXCR2 expression on mononuclear cells | Modulating IL-27 signaling improves outcomes in neonatal sepsis |
| CXCR2 | Chemokine receptor whose expression is sustained by IL-27 inhibition, affecting migration | Target for regulating mononuclear cell recruitment in sepsis |
| HMGB1 | Pro-inflammatory mediator that regulates monocyte migration | Potential target to modulate monocyte trafficking |
| MAP4K1 | MAP4K family kinase involved in immunity and inflammation | Kinase inhibitor development for inflammatory diseases |
| MAP4K4 | MAP4K family kinase that negatively regulates mononuclear cell migration | Drug target for anti-inflammatory therapies |
| DICAM | Adhesion molecule on mononuclear phagocytes controlling neuroinflammation | Biomarker and therapeutic target in multiple sclerosis |
| VAULT | Drug resistance-related ribonucleoprotein particles upregulated during dendritic cell development | Link between drug resistance and immune cell migration |
| EPC | Endothelial progenitor cells down-regulated in Kawasaki disease | Marker of vascular inflammation and repair |
| HEDL | Negative regulation of human mononuclear phagocyte function | Studying anti-inflammatory mechanisms |
| MTOR | Central regulator of cell growth and metabolism, may influence migration | Target for immunometabolism studies |
| NFKB1 | Transcription factor controlling inflammatory gene expression | Modulating mononuclear cell activation |
| STAT3 | Signal transducer downstream of IL-27, affecting chemokine production | Therapeutic target in sepsis and autoimmunity |
| ITGAM | Integrin alpha M involved in monocyte adhesion and migration | Target for blocking tissue infiltration |
| CCR2 | Chemokine receptor mediating monocyte egress from bone marrow | Modulating monocyte recruitment in inflammation |
| CD14 | Monocyte surface marker involved in LPS sensing | Studying mononuclear phagocyte function |
| PTPRC | CD45, regulates Src family kinases in immune cells | Modulating migratory signaling |
| RAC1 | Rho GTPase controlling cytoskeletal dynamics during migration | Target for inhibiting cell motility |
How Is negative regulation of mononuclear cell migration Regulated?
Negative regulation of mononuclear cell migration is controlled by a network of anti-inflammatory cytokines, chemokines, and intracellular signaling pathways. IL-27 signaling plays a central role by regulating chemokine levels and sustaining CXCR2 expression on mononuclear cells, thereby influencing their migratory capacity. MAP4K family kinases act as intracellular brakes on migration by modulating cytoskeletal rearrangements and integrin activation. Additionally, HMGB1 can regulate monocyte migration, and its effects are context-dependent. The balance between pro-migratory and anti-migratory signals determines the net rate of mononuclear cell infiltration, and dysregulation of these pathways contributes to inflammatory diseases.
negative regulation of mononuclear cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DICAM | Multiple sclerosis / neuroinflammation | EAE mouse model with DICAM knockout |
| IL27 | Gram-negative neonatal sepsis | Neonatal sepsis mouse model with IL-27 inhibition |
| VAULT | Drug resistance in cancer | Dendritic cell development model with vault overexpression |
| EPC | Kawasaki disease / vasculitis | Mouse model of Kawasaki disease |
| HMGB1 | Inflammation and sepsis | HMGB1 knockout mice in monocyte migration assays |
Multiple Sclerosis and Neuroinflammation
In multiple sclerosis, DICAM-positive mononuclear phagocytes play a role in controlling neuroinflammation, and impaired negative regulation of mononuclear cell migration can lead to excessive immune cell infiltration into the central nervous system, causing demyelination and neuronal damage. Targeting the migratory machinery of mononuclear phagocytes is a promising therapeutic strategy for neuroinflammatory diseases.
Sepsis and Infectious Diseases
In gram-negative neonatal sepsis, inhibition of IL-27 signaling regulates chemokine levels and sustains CXCR2 receptor expression on mononuclear cells, improving disease outcomes. This highlights how manipulating the negative regulation of mononuclear cell migration can enhance pathogen clearance while limiting tissue damage. HMGB1 also regulates monocyte migration and may contribute to sepsis pathogenesis.
Cancer and Drug Resistance
Vault particles, which are drug resistance-related ribonucleoprotein complexes, are upregulated during dendritic cell development, linking mononuclear cell biology to chemoresistance. Negative regulation of mononuclear cell migration can influence the tumor microenvironment by limiting the recruitment of tumor-associated macrophages, which may affect tumor progression and response to therapy.
Kawasaki Disease and Vascular Inflammation
Endothelial progenitor cell down-regulation has been observed in a mouse model of Kawasaki disease, a vasculitis that involves mononuclear cell infiltration of blood vessels. This suggests that negative regulation of mononuclear cell migration may be impaired in Kawasaki disease, contributing to vascular inflammation.
From negative regulation of mononuclear cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate mononuclear cell migration? | Knockout of gene X in monocyte/macrophage cell lines followed by transwell migration assay |
| Does a specific point mutation in gene X affect its anti-migratory function? | Point mutation knock-in using CRISPR in primary monocytes |
| Does overexpression of gene X reduce mononuclear cell infiltration in vivo? | Knock-in of a constitutive promoter or overexpression vector in mouse models |
| Where is gene X expressed in migrating mononuclear cells? | Tagged knock-in with fluorescent protein for live imaging |
| What is the effect of gene X on chemokine receptor expression? | Knockout and RNA-seq of mononuclear cells |
| Can CRISPR library screening identify novel negative regulators of migration? | Genome-wide CRISPR knockout screen in monocyte cell line |
How to Study the negative regulation of mononuclear cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Assessing negative regulation of monocyte migration |
| Flow cytometry | Surface marker and chemokine receptor expression | Quantifying CXCR2 on mononuclear cells |
| Intravital microscopy | Real-time cell migration in tissues | Visualizing mononuclear phagocyte infiltration |
| CRISPR knockout | Gene function loss | Identifying negative regulators of migration |
| RNA-seq | Transcriptional changes | Profiling chemokine and receptor genes |
| Proteomics | Protein expression and modifications | Detecting vault particle upregulation |
| CRISPR library screening | Genome-wide functional screen | Discovering novel anti-migratory genes |
| ELISA | Cytokine and chemokine levels | Measuring IL-27 and CXCR2 ligands |
Transwell Migration Assays
Transwell migration assays are the gold standard for measuring mononuclear cell migration in vitro. Cells are placed in the upper chamber and chemoattractants in the lower chamber; the number of cells that migrate through the membrane is quantified. This method has been used to study the effects of HMGB1 on monocyte migration and to assess the role of IL-27 in regulating CXCR2 expression.
Flow Cytometry and Imaging
Flow cytometry allows quantification of mononuclear cell subsets and their expression of chemokine receptors and adhesion molecules. Imaging techniques such as intravital microscopy can visualize mononuclear cell migration in real time within tissues. These approaches have been used to study DICAM-positive mononuclear phagocytes in neuroinflammation and vault particle upregulation during dendritic cell development.
CRISPR-Cas9 Functional Genomics
CRISPR-Cas9 knockout, knock-in, and overexpression models enable precise manipulation of genes involved in negative regulation of mononuclear cell migration. Genome-wide CRISPR screens can identify novel regulators of migration. MAP4K family kinases have been studied using genetic approaches to dissect their roles in immunity and inflammation.
Transcriptomics and Proteomics
RNA-seq and proteomics can reveal changes in gene expression and protein abundance associated with negative regulation of mononuclear cell migration. For example, transcriptomic analysis of mononuclear cells after IL-27 inhibition has identified changes in chemokine and receptor expression. These methods provide a systems-level view of the regulatory networks involved.
How CRISPR Can Be Used to Study GO:0071676 negative regulation of mononuclear cell migration
Knockout
CRISPR knockout of candidate genes such as IL27, CXCR2, or MAP4K4 in mononuclear cell lines or primary cells can reveal their role in negative regulation of migration. For example, knocking out MAP4K4 may enhance migration, confirming its negative regulatory function. Knockout models are essential for loss-of-function studies.
Point Mutation
Point mutation knock-in using CRISPR can model disease-associated variants or phospho-null mutants to dissect signaling pathways. For instance, mutating specific phosphorylation sites in MAP4K family kinases can determine their impact on anti-migratory signaling. This approach provides mechanistic insights beyond simple knockout.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP) into endogenous loci allows tracking of gene expression and protein localization during mononuclear cell migration. Tagged knock-in of DICAM can help visualize its role in neuroinflammation. Knock-in of constitutively active or inactive alleles can also test causality.
Overexpression
Overexpression of candidate negative regulators such as IL-27 or DICAM in mononuclear cells can suppress migration and reduce inflammation in disease models. CRISPR-mediated overexpression via safe-harbor locus integration provides stable and controlled expression for functional studies.
How EDITGENE Supports negative regulation of mononuclear cell migration Research
Researchers studying negative regulation of mononuclear cell migration-related genes often need to determine whether a candidate gene is causally involved in restraining immune cell trafficking. EDITGENE provides end-to-end CRISPR services to accelerate this discovery process, from knockout and point mutation to knock-in and overexpression models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mononuclear cell migration research.
Frequently Asked Questions About negative regulation of mononuclear cell migration
What is GO:0071676?
GO:0071676 is the Gene Ontology term for negative regulation of mononuclear cell migration, defined as any process that decreases the rate, frequency or extent of mononuclear cell migration.
What genes are involved in negative regulation of mononuclear cell migration?
Key genes include IL27, CXCR2, MAP4K family kinases, DICAM, HMGB1, and vault particle components, as identified in published studies.
How is mononuclear cell migration negatively regulated?
It is regulated by anti-inflammatory cytokines like IL-27, intracellular kinases such as MAP4K, and surface molecules like DICAM that dampen chemotaxis and adhesion.
Why is negative regulation of mononuclear cell migration important in disease?
It prevents excessive immune cell infiltration and tissue damage; dysregulation contributes to multiple sclerosis, sepsis, and cancer.
What experimental models are used to study negative regulation of mononuclear cell migration?
Transwell assays, flow cytometry, intravital microscopy, and CRISPR knockout/knock-in models are commonly used.
How does IL-27 affect mononuclear cell migration?
IL-27 signaling regulates chemokine levels and sustains CXCR2 expression on mononuclear cells, thereby modulating their migration.
What is the role of MAP4K kinases in mononuclear cell migration?
MAP4K family kinases act as negative regulators of mononuclear cell migration by interfering with cytoskeletal dynamics and integrin signaling.
Can CRISPR be used to study negative regulation of mononuclear cell migration?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise manipulation of genes involved in this process.
What diseases are linked to defective negative regulation of mononuclear cell migration?
Multiple sclerosis, gram-negative neonatal sepsis, Kawasaki disease, and cancer have been associated with altered regulation.
How can I screen for novel regulators of mononuclear cell migration?
Genome-wide CRISPR library screening in monocyte cell lines followed by transwell migration assays can identify novel negative regulators.
Conclusion
GO:0071676, negative regulation of mononuclear cell migration, is a critical biological process that restrains immune cell trafficking to prevent tissue damage and maintain homeostasis. Its dysregulation is implicated in a range of diseases, from neuroinflammation to sepsis and cancer, making it a compelling target for therapeutic intervention. Advances in CRISPR-based functional genomics and bioinformatics are accelerating the discovery of key regulatory genes and pathways. EDITGENE provides comprehensive CRISPR services to support researchers in dissecting this process and translating findings into clinical applications.
References
- 1. Hedl M et al.. 2013. Negative regulation of human mononuclear phagocyte function.. Mucosal Immunol 6(2):205-23 PMID: 23340822
- 2. Rouhiainen A et al.. 2004. Regulation of monocyte migration by amphoterin (HMGB1).. Blood 104(4):1174-82 PMID: 15130941
- 3. Schroeijers AB et al.. 2002. Up-regulation of drug resistance-related vaults during dendritic cell development.. J Immunol 168(4):1572-8 PMID: 11823484
- 4. Xuan F et al.. 2025. Identification of the prognostic effect of mitophagy-related genes in acute myeloid leukemia.. Front Immunol 16:1580597 PMID: 40873580
- 5. Annamanedi M et al.. 2025. Inhibition of IL-27 signaling regulates chemokine levels and sustains CXCR2 receptor expression on mononuclear cells to improve disease outcomes during gram-negative neonatal sepsis.. Front Immunol 16:1653355 PMID: 40977737
- 6. Chuang HC et al.. 2016. MAP4K Family Kinases in Immunity and Inflammation.. Adv Immunol 129:277-314 PMID: 26791862
- 7. von Essen MR et al.. 2025. A role for DICAM(+) mononuclear phagocytes in controlling neuroinflammation in multiple sclerosis.. Front Immunol 16:1628398 PMID: 40791582
- 8. Liu JF et al.. 2012. Endothelial progenitor cell down-regulation in a mouse model of Kawasaki disease.. Chin Med J (Engl) 125(3):496-501 PMID: 22490410
